School of Medicine, University of Auckland, Auckland, New Zealand.
School of Population Health, University of Auckland, Auckland, New Zealand.
Am J Gastroenterol. 2019 May;114(5):804-812. doi: 10.14309/ajg.0000000000000225.
To investigate the risk of mortality and hospitalization in individuals with post-pancreatitis diabetes mellitus (PPDM) compared with those with type 2 diabetes mellitus (T2DM).
Using nationwide hospital discharge data on pancreatitis and diabetes in New Zealand (n = 231,943), a total of 959 individuals with PPDM were identified. For each individual with PPDM, 10 age- and sex-matched individuals with T2DM were randomly selected. Multivariable Cox regression analysis was conducted, and the risk was expressed as hazard ratio (HR) and 95% confidence interval (CI).
A total of 3,867 deaths occurred among 10,549 study individuals. Individuals with PPDM had all-cause mortality rate at 80.5 (95% CI, 70.3-90.6) per 1,000 person-years, which was higher compared with T2DM individuals (adjusted HR, 1.13 (95% CI, 1.00-1.29); absolute excess risk, 14.8 (95% CI, 4.5-25.2) per 1,000 person-years). Compared with T2DM, PPDM was associated with higher risks of mortality from cancer (adjusted HR, 1.44; 95% CI, 1.13-1.83), infectious disease (adjusted HR, 2.52; 95% CI, 1.69-3.77), and gastrointestinal disease (adjusted HR, 2.56; 95% CI, 1.64-4.01). Individuals with PPDM vs T2DM were also at significantly higher risks of hospitalization for chronic pulmonary disease, moderate to severe renal disease, and infectious disease.
Individuals with PPDM have higher risk of mortality and hospitalization compared with individuals with T2DM. Guidelines for management of PPDM need to be developed with a view to preventing excess deaths and hospitalizations in individuals with PPDM.
研究与 2 型糖尿病(T2DM)患者相比,胰腺炎后糖尿病(PPDM)患者的死亡率和住院率风险。
利用新西兰全国性胰腺炎和糖尿病住院数据(n=231943),共确定了 959 例 PPDM 患者。对于每例 PPDM 患者,随机选择 10 例年龄和性别匹配的 T2DM 患者。采用多变量 Cox 回归分析,风险表示为风险比(HR)和 95%置信区间(CI)。
在 10549 名研究对象中,共有 3867 人死亡。PPDM 患者的全因死亡率为 80.5(95%CI,70.3-90.6)/1000 人年,高于 T2DM 患者(校正 HR,1.13(95%CI,1.00-1.29);绝对超额风险,14.8(95%CI,4.5-25.2)/1000 人年)。与 T2DM 相比,PPDM 与癌症(校正 HR,1.44;95%CI,1.13-1.83)、传染病(校正 HR,2.52;95%CI,1.69-3.77)和胃肠道疾病(校正 HR,2.56;95%CI,1.64-4.01)的死亡率风险增加有关。与 T2DM 相比,PPDM 患者因慢性肺部疾病、中重度肾功能障碍和传染病住院的风险也显著增加。
与 T2DM 患者相比,PPDM 患者的死亡率和住院率风险更高。需要制定 PPDM 管理指南,以防止 PPDM 患者的死亡和住院人数增加。